Sherven Sharma

University Of California Los Angeles

$2,093,761

Attributed

$2,093,761

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $287.6K · FY2005–20

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$2,093,761 · 2

VA$0 · 2

By mechanism

R01$1,420,721 · 1

K01$673,040 · 1

I01$0 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of California Los Angeles

Same institution · by research overlap

Antoni Ribas$28,929,216
Robert M Prins$8,963,397
Heather Christofk$9,647,151
Paul Wender$20,449,594
Zoran Galic$3,509,989

Others in their field

Top investigators on “Chemokine”

David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
Andrew D Luster · Massachusetts General Hospital$27,938,802
Joan Weinberger Berman · Yeshiva University$24,229,643
Larry Arthur$22,516,306
Maurizio Fava · Massachusetts General Hospital$19,116,294
Lionel B Ivashkiv · Hospital For Special Surgery$18,420,856

Research focus

ChemokineImmune ResponseDiagnosisTumor BurdenTumorCancer EtiologyImmuneCessation Of LifeT-LymphocyteTumor AntigensMalignant Neoplasm Of LungResponseMediatingGene-ModifiedLung NeoplasmsCcl21 GeneBaseCancer PatientDendritic CellsAntibodiesMyelogenousSuppressor-Effector T-LymphocytesCd8b1 GeneCytokine